Catalent Expands Capabilities At German Facility
Catalent Pharma Solutions (Somerset, NJ) expands capabilities in the company’s Schorndorf, Germany site, to include a new potent products area. This important new capability enables Catalent to provide customers with complex and innovative dose-form production, over-encapsulation, and packaging solutions for potent products at its Schorndorf site.
“We believe the addition of this new potent handling and over-encapsulation area will help to meet the needs of our customers, both global and local,” says Eric Schmidhaeuser, managing director of the Schorndorf operation, Catalent. “I am also pleased that this investment was made here in Schorndorf, as it builds upon our team’s commitment to operational excellence, our regulatory track record, and our consistent focus on meeting our customers’ needs.”
For about 50 years, Catalent’s Schorndorf operation has provided a broad range of services to global, regional, and local pharmaceutical customers. Today, Catalent provides oral dose form development, manufacturing, and packaging services, as well as comprehensive supply chain solutions.
In the fall of 2009, Catalent’s Schorndorf facility successfully completed an FDA inspection adding to a long track record of regulatory compliance, including German and other European Union and international regulatory authorities.